- Home
- RCUS vs FBK Comparison
RCUS vs FBK Comparison
Compare RCUS & FBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RCUS | FBK |
|---|---|---|
| Founded | 2015 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.8B |
| IPO Year | 2018 | 2016 |
Fundamental Metrics
Financial Performance| Metric | RCUS | FBK |
|---|---|---|
| Price | $24.31 | $53.75 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 4 |
| Target Price | $31.90 | ★ $64.50 |
| AVG Volume (30 Days) | ★ 1.0M | 299.5K |
| Earning Date | 05-05-2026 | 04-13-2026 |
| Dividend Yield | N/A | ★ 1.56% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.10 |
| Revenue | ★ $247,000,000.00 | N/A |
| Revenue This Year | N/A | $41.72 |
| Revenue Next Year | $45.62 | $7.21 |
| P/E Ratio | ★ N/A | $48.69 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $7.92 | $45.10 |
| 52 Week High | $28.72 | $62.37 |
Technical Indicators
Market Signals| Indicator | RCUS | FBK |
|---|---|---|
| Relative Strength Index (RSI) | 52.04 | 52.11 |
| Support Level | $23.91 | $52.99 |
| Resistance Level | $24.33 | $54.23 |
| Average True Range (ATR) | 1.45 | 1.18 |
| MACD | 0.04 | 0.10 |
| Stochastic Oscillator | 57.31 | 50.78 |
Price Performance
Historical ComparisonAbout RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.
About FBK FB Financial Corporation
FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates majority of revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.